Page 1 | Search Results | Clinical Cancer Research | American Association for Cancer Research

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma

Clin Cancer Res (2018) 24 (16): 3928–3940.

https://doi.org/10.1158/1078-0432.CCR-17-3060

Published: 14 August 2018

View article titled, Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma

Includes: Supplementary data

Journal Articles

Abstract A37: Dual wavelength near-infrared fluorescence imaging of VEGF-A and IGF-1R in ovarian cancer patient-derived xenografts

Tushar Tomar, Nicolette G. Alkema, Jolanda A.L. Visser, Anton G. Terwisscha van Scheltinga, Gert Jan Meersma, Harry G. Klip, Evelien W. Duiker, Elisabeth G.E. De Vries, Ate G.J. Van der Zee, Steven De Jong

Clin Cancer Res (2016) 22 (16_Supplement): A37.

https://doi.org/10.1158/1557-3265.PDX16-A37

Published: 15 August 2016

View article titled, Abstract A37: Dual wavelength near-infrared fluorescence imaging of VEGF-A and IGF-1R in ovarian cancer patient-derived xenografts

Journal Articles

Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer

Maartje C.A. Wouters, Fenne L. Komdeur, Hagma H. Workel, Harry G. Klip, Annechien Plat, Neeltje M. Kooi, G. Bea A. Wisman, Marian J.E. Mourits, Henriette J.G. Arts, Maaike H.M. Oonk, Refika Yigit, Steven de Jong, Cornelis J.M. Melief, Harry Hollema, Evelien W. Duiker, Toos Daemen, Marco de Bruyn, Hans W. Nijman

Clin Cancer Res (2016) 22 (3): 714–724.

https://doi.org/10.1158/1078-0432.CCR-15-1617

Published: 31 January 2016

View article titled, Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer

Includes: Supplementary data

Journal Articles

Pharmacomethylomics: methylation profiling applied to drug resistance models

Josef Straub, Pauline de Graef, Geert Trooskens, Katja Bierau, Steven de Jong, Joseph W. Bigley, Ate van der Zee, Herman Spolders, Wim MR Van Criekinge

Clin Cancer Res (2006) 12 (19_Supplement): A95.

Published: 15 August 2014

View article titled, Pharmacomethylomics: methylation profiling applied to drug resistance models

Journal Articles

Measurement of Tumor VEGF-A Levels with ⁸⁹Zr-Bevacizumab PET as an Early Biomarker for the Antiangiogenic Effect of Everolimus Treatment in an Ovarian Cancer Xenograft Model

Arne R.M. van der Bilt, Anton G.T. Terwisscha van Scheltinga, Hetty Timmer-Bosscha, Carolien P. Schröder, Linda Pot, Jos G.W. Kosterink, Ate G.J. van der Zee, Marjolijn N. Lub-de Hooge, Steven de Jong, Elisabeth G.E. de Vries, Anna K.L. Reyners

Clin Cancer Res (2012) 18 (22): 6306–6314.

https://doi.org/10.1158/1078-0432.CCR-12-0406

Published: 14 November 2012

View article titled, Measurement of Tumor VEGF-A Levels with 89Zr-Bevacizumab PET as an Early Biomarker for the Antiangiogenic Effect of Everolimus Treatment in an Ovarian Cancer Xenograft Model

Includes: Supplementary data

Journal Articles

Enhanced Antitumor Efficacy of a DR5-Specific TRAIL Variant over Recombinant Human TRAIL in a Bioluminescent Ovarian Cancer Xenograft Model

Evelien W. Duiker, Elisabeth G.E. de Vries, Devalingam Mahalingam, Gert Jan Meersma, Wytske Boersma-van Ek, Harry Hollema, Marjolijn N. Lub-de Hooge, Go M. van Dam, Robbert H. Cool, Wim J. Quax, Afshin Samali, Ate G.J. van der Zee, Steven de Jong

Clin Cancer Res (2009) 15 (6): 2048–2057.

https://doi.org/10.1158/1078-0432.CCR-08-1535

Published: 16 March 2009

View article titled, Enhanced Antitumor Efficacy of a DR5-Specific TRAIL Variant over Recombinant Human TRAIL in a Bioluminescent Ovarian Cancer Xenograft Model

Includes: Supplementary data

Journal Articles

JC Virus Infection in Colorectal Neoplasia That Develops after Liver Transplantation

Michael Selgrad, Jan Jacob Koornstra, Lucia Fini, Marloes Blom, Rong Huang, Edward B. DeVol, Wytske Boersma-van Ek, Gerard Dijkstra, Robert C. Verdonk, Steven de Jong, Ajay Goel, Sharenda L. Williams, Richard L. Meyer, Elizabeth B. Haagsma, Luigi Ricciardiello, C. Richard Boland

Clin Cancer Res (2008) 14 (20): 6717–6721.

https://doi.org/10.1158/1078-0432.CCR-08-0961

Published: 16 October 2008

View article titled, JC Virus Infection in Colorectal Neoplasia That Develops after Liver Transplantation

Journal Articles

TRAIL Induces Apoptosis in Human Colorectal Adenoma Cell Lines and Human Colorectal Adenomas

Mathilde Jalving, Steven de Jong, Jan J. Koornstra, Wytske Boersma-van Ek, Nynke Zwart, Jelle Wesseling, Elisabeth G.E. de Vries, Jan H. Kleibeuker

Clin Cancer Res (2006) 12 (14): 4350–4356.

https://doi.org/10.1158/1078-0432.CCR-05-2487

Published: 20 July 2006

View article titled, TRAIL Induces Apoptosis in Human Colorectal Adenoma Cell Lines and Human Colorectal Adenomas

Journal Articles

Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Pathway and Its Therapeutic Implications

Elisabeth G.E. de Vries, Jourik A. Gietema, Steven de Jong

Clin Cancer Res (2006) 12 (8): 2390–2393.

https://doi.org/10.1158/1078-0432.CCR-06-0352

Published: 25 April 2006

View article titled, Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Pathway and Its Therapeutic Implications

Journal Articles

Expression of TRAIL and TRAIL Death Receptors in Stage III Non-Small Cell Lung Cancer Tumors

Diana C. J. Spierings, Elisabeth G. E. de Vries, Wim Timens, Harry J. M. Groen, H. Marike Boezen, Steven de Jong

Clin Cancer Res (2003) 9 (9): 3397–3405.

Published: 05 September 2003

View article titled, Expression of TRAIL and TRAIL Death Receptors in Stage III Non-Small Cell Lung Cancer Tumors

Journal Articles

Correspondence re: C. G. Ferreira et al. , Apoptosis: Target of Cancer Therapy. Clin. Cancer Res., 8: 2024–2034, 2002.

Elisabeth G. E. de Vries, Marjolein N. de Hooge, Jourik A. Gietema, Steven de Jong

Clin Cancer Res (2003) 9 (2): 912.

Published: 01 February 2003

View article titled, Correspondence re: C. G. Ferreira et al. , Apoptosis: Target of Cancer Therapy. Clin. Cancer Res., 8: 2024–2034, 2002.

NARROW

Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma

Abstract A37: Dual wavelength near-infrared fluorescence imaging of VEGF-A and IGF-1R in ovarian cancer patient-derived xenografts

Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer

Pharmacomethylomics: methylation profiling applied to drug resistance models

Measurement of Tumor VEGF-A Levels with ⁸⁹Zr-Bevacizumab PET as an Early Biomarker for the Antiangiogenic Effect of Everolimus Treatment in an Ovarian Cancer Xenograft Model

Enhanced Antitumor Efficacy of a DR5-Specific TRAIL Variant over Recombinant Human TRAIL in a Bioluminescent Ovarian Cancer Xenograft Model

JC Virus Infection in Colorectal Neoplasia That Develops after Liver Transplantation

TRAIL Induces Apoptosis in Human Colorectal Adenoma Cell Lines and Human Colorectal Adenomas

Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Pathway and Its Therapeutic Implications

Expression of TRAIL and TRAIL Death Receptors in Stage III Non-Small Cell Lung Cancer Tumors

Correspondence re: C. G. Ferreira et al. , Apoptosis: Target of Cancer Therapy. Clin. Cancer Res., 8: 2024–2034, 2002.

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only